Oramed Pharmaceuticals Inc Earnings

The next earnings date for Oramed Pharmaceuticals Inc is February 25, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Oramed Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
02/25/2026	$-0.08

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Oramed Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
11/14/2025	---	$0	100.00%
08/26/2025	---	$0.31	3,200.00%
08/19/2025	---	$0.31	3,200.00%
08/13/2025	---	$0	100.00%
05/07/2025	After Market	---	---
03/04/2025	After Market	---	---
11/07/2024	After Market	$-0.48	-1,300.00%
08/08/2024	After Market	$0.26	2,500.00%
05/09/2024	After Market	$0.04	100.00%
03/06/2024	After Market	$0.33	375.00%
11/10/2023	Before Market	$-0.08	0.00%
08/10/2023	After Market	$-0.03	70.00%
05/11/2023	After Market	$-0.08	69.23%
03/06/2023	After Market	$-0.22	4.35%
11/10/2022	After Market	$-0.18	28.00%
08/10/2022	After Market	$-0.27	-22.73%
05/12/2022	After Market	$-0.27	-17.39%
01/11/2022	After Market	$-0.22	-37.50%
11/24/2021	After Market	$-0.21	-16.67%
07/14/2021	After Market	$-0.17	15.00%
04/13/2021	After Market	$-0.17	0.00%
01/14/2021	After Market	$-0.23	-64.29%
11/24/2020	Before Market	$-0.12	42.86%
07/07/2020	After Market	$-0.10	41.18%
04/06/2020	After Market	$-0.21	-23.53%
01/08/2020	---	$-0.15	34.78%
11/27/2019	After Market	$-0.13	45.83%
07/10/2019	After Market	$-0.23	0.00%
04/10/2019	After Market	$-0.21	12.50%
01/14/2019	After Market	$-0.25	-31.58%
11/28/2018	After Market	$-0.18	37.93%
07/13/2018	Before Market	$-0.30	-3.45%
04/09/2018	After Market	$-0.20	31.03%
01/11/2018	After Market	$-0.18	25.00%
11/01/2017	---	$-0.20	13.04%
07/06/2017	After Market	$-0.15	44.44%
04/05/2017	After Market	$-0.24	-4.22%
01/11/2017	After Market	$-0.20	-66.67%
11/25/2016	After Market	$-0.37	-105.56%
07/06/2016	Before Market	$-0.15	25.00%
04/06/2016	After Market	$-0.14	26.32%
01/13/2016	After Market	$-0.21	-10.53%
11/25/2015	After Market	$-0.19	-5.56%
07/01/2015	After Market	$-0.15	16.67%
04/03/2015	After Market	$-0.15	31.82%
01/08/2015	After Market	$-0.19	9.52%
11/14/2014	After Market	$-0.17	15.00%
07/14/2014	---	$-0.18	-20.00%
04/10/2014	---	$-0.12	33.33%
01/14/2014	---	$-0.14	12.50%
10/30/2013	---	$-0.11	---
07/31/2013	---	$-0.17	---
02/28/2013	---	$-0.17	---
11/30/2012	---	$-0.14	---
08/31/2012	---	$-0.23	---
05/31/2012	---	$-0.09	---
02/29/2012	---	$-0.17	---
11/30/2011	---	$-0.08	---
08/31/2011	---	$-0.14	---
05/31/2011	---	$0.08	---
02/28/2011	---	$-0.12	---
11/30/2010	---	$-0.12	---
08/31/2010	---	$-0.25	---
05/31/2010	---	$-0.17	---
02/28/2010	---	$-0.08	---
11/30/2009	---	$-0.13	---
08/31/2009	---	$-0.08	---
05/31/2009	---	$-0.11	---
02/28/2009	---	$-0.14	---
11/30/2008	---	$-0.25	---
08/31/2008	---	$-0.00	---
05/31/2008	---	$-0.21	---
02/29/2008	---	$-0.09	---
11/30/2007	---	$-0.09	---
08/31/2007	---	$-0.72	---
05/31/2007	---	$-0.09	---
02/28/2007	---	$-0.10	---
11/30/2006	---	$-0.02	---
08/31/2006	---	$-0.08	---
05/31/2006	---	$-0.05	---
02/28/2006	---	$-0.00	---
11/30/2005	---	$-0.00	---

More About Oramed Pharmaceuticals Inc

Website

https://www.oramed.com

Country

USA

Full Time Employees

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

“Oramed Pharmaceuticals Inc Earnings” Can Refer to the Oramed Pharmaceuticals Inc Earnings Date

Some people say “Oramed Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Oramed Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Oramed Pharmaceuticals Inc Stock on the Earnings Date

If you own Oramed Pharmaceuticals Inc stock (ORMP) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Oramed Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Oramed Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Oramed Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Oramed Pharmaceuticals Inc earnings or anything else related to the stock market.